Variant report

Variant	rs16965880
Chromosome Location	chr17:38673928-38673929
allele	A/G
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Distal block	Cell Line	Cell type
1	chr17:38604010..38606679-chr17:38673420..38675786,2	MCF-7	breast:
2	chr17:38654640..38659414-chr17:38673768..38679140,6	MCF-7	breast:
3	chr17:38472782..38476711-chr17:38671565..38675024,4	MCF-7	breast:
4	chr17:38673323..38675272-chr17:38683066..38684839,2	K562	blood:
5	chr17:38673127..38676333-chr17:38678075..38682047,4	K562	blood:

Variant related genes	Relation type
ENSG00000131746	Chromatin interaction
ENSG00000131759	Chromatin interaction
ENSG00000266088	Chromatin interaction

Extended variants
information (count: 2 )
Associated
traits (count: 0)

rSNPs within LD-proxies of this variant (count:1)

rs_ID	r²[population]
rs8077724	1.00[YRI][hapmap]

Variant overlapped rSNPs/rCNVs (count:1 , 50 per page) page: 1

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	nsv1058185	chr17:38629339-38689908	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer Genic enhancers Active TSS Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' ZNF genes & repeats Strong transcription Bivalent/Poised TSS	TF binding region CpG island Chromatin interactive region lncRNA	11 gene(s)	inside rSNPs	diseases

No data

Chromatin state (count:79 , 50 per page) page: 1 2

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr17:38666800-38674400	Weak transcription	Pancreas	Pancrea
2	chr17:38666800-38675000	Weak transcription	ES-UCSF4 Cell Line	embryonic stem cell
3	chr17:38666800-38677400	Weak transcription	Right Atrium	heart
4	chr17:38668200-38677400	Weak transcription	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
5	chr17:38668400-38680600	Weak transcription	iPS DF 6.9 Cell Line	embryonic stem cell
6	chr17:38668600-38675200	Weak transcription	Gastric	stomach
7	chr17:38668800-38674600	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
8	chr17:38671400-38674000	Flanking Active TSS	Primary T helper cells PMA-I stimulated	--
9	chr17:38671400-38675400	Enhancers	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
10	chr17:38671400-38679800	Enhancers	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
11	chr17:38671600-38674000	Flanking Active TSS	Primary T helper cells fromperipheralblood	blood
12	chr17:38671600-38679400	Enhancers	Placenta	Placenta
13	chr17:38671800-38674000	Flanking Active TSS	Primary T cells fromperipheralblood	blood
14	chr17:38671800-38674800	Enhancers	Primary hematopoietic stem cells	blood
15	chr17:38672200-38679200	Enhancers	IMR90 fetal lung fibroblasts Cell Line	lung
16	chr17:38672400-38674600	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Female	--
17	chr17:38672600-38674000	Flanking Active TSS	Primary T cells from cord blood	blood
18	chr17:38672600-38674000	Flanking Active TSS	Primary T helper memory cells from peripheral blood 2	blood
19	chr17:38672600-38675000	Flanking Active TSS	Primary B cells from cord blood	blood
20	chr17:38672600-38675200	Enhancers	Osteobl	bone
21	chr17:38672600-38675600	Enhancers	Rectal Mucosa Donor 31	rectum
22	chr17:38672600-38680800	Enhancers	Placenta Amnion	Placenta Amnion
23	chr17:38672800-38674000	Flanking Active TSS	Primary T killer memory cells from peripheral blood	blood
24	chr17:38672800-38674000	Flanking Active TSS	Foreskin Keratinocyte Primary Cells skin02	Skin
25	chr17:38672800-38674000	Flanking Active TSS	Foreskin Keratinocyte Primary Cells skin03	Skin
26	chr17:38672800-38674000	Flanking Active TSS	Dnd41	blood
27	chr17:38672800-38674000	Flanking Active TSS	Hela-S3	cervix
28	chr17:38672800-38674000	Flanking Active TSS	NHEK	skin
29	chr17:38672800-38674000	Enhancers	NHLF	lung
30	chr17:38672800-38674400	Enhancers	Foreskin Fibroblast Primary Cells skin02	Skin
31	chr17:38672800-38679200	Enhancers	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
32	chr17:38673000-38676000	Enhancers	NH-A	brain
33	chr17:38673200-38674200	Weak transcription	HUES6 Cell Line	embryonic stem cell
34	chr17:38673200-38674400	Weak transcription	iPS-20b Cell Line	embryonic stem cell
35	chr17:38673200-38674800	Enhancers	Fetal Adrenal Gland	Adrenal Gland
36	chr17:38673200-38676000	Enhancers	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
37	chr17:38673400-38674400	Weak transcription	ES-I3 Cell Line	embryonic stem cell
38	chr17:38673400-38674400	Weak transcription	H9 Cell Line	embryonic stem cell
39	chr17:38673400-38674600	Weak transcription	HUES64 Cell Line	embryonic stem cell
40	chr17:38673400-38676000	Enhancers	K562	blood
41	chr17:38673600-38674200	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Male	--
42	chr17:38673600-38674400	Weak transcription	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
43	chr17:38673600-38674400	Weak transcription	Lung	lung
44	chr17:38673600-38674600	Enhancers	Primary mononuclear cells fromperipheralblood	Blood
45	chr17:38673600-38675000	Weak transcription	NHDF-Ad	bronchial
46	chr17:38673600-38675200	Enhancers	Primary hematopoietic stem cells short term culture	blood
47	chr17:38673600-38675400	Enhancers	HSMM	muscle
48	chr17:38673600-38675600	Enhancers	Primary T cells effector/memory enriched fromperipheralblood	blood
49	chr17:38673600-38675600	Enhancers	Foreskin Fibroblast Primary Cells skin01	Skin
50	chr17:38673600-38675800	Enhancers	Primary T regulatory cells fromperipheralblood	blood

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links